Brief: Lansen Pharmaceutical FY Profit Attributable US$88.2 Million
30/03/2021 16:22
March 30 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* FY PROFIT ATTRIBUTABLE US$88.2 MILLION VERSUS US$18.3
MILLION
* FY TOTAL REVENUE OF US$54.4 MLN, INCREASE OF 0.2%
Source text for Eikon: urn:newsml:reuters.com:*:nHKSDTbQZ
Further company coverage: 0503.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year